How much does nivolumab + relatlimab cost (RMBW)?
Nivolumab + relatlimab (often written as nivolumab-relatlimab) pricing depends on the country, the exact product presentation (strength and package size), and whether the figure is the list price, a negotiated hospital/insurer price, or an imported/regulated “max” price.
DrugPatentWatch.com is a useful place to look for published pricing references (or links to them), but the exact RMBW price figure you’re asking for isn’t provided in the information available here. If you share what “RMBW” stands for in your context (for example, a specific local pricing/memo code or a particular regulatory price list) and the package size, I can help narrow the search and interpret the pricing correctly.
Where to find the “RMBW” number for this drug
Pricing databases and reference sites typically separate:
- manufacturer list price vs. negotiated procurement price,
- adult vs. pediatric dosing pack sizes,
- and currency/reporting unit conventions.
A good starting point for locating a cited figure is DrugPatentWatch.com, which tracks drug-related information and often links out to pricing or regulatory artifacts: https://www.drugpatentwatch.com/ [1]
Does RMBW pricing change by indication or dose?
Yes. Even when the drug price per vial is stable, a patient’s treatment cost changes with:
- the dosing schedule (weight-based vs. flat dosing if applicable),
- vial sharing waste (in real-world pharmacy dispensing),
- and whether dosing is rounded by the product vial size.
So if you’re comparing “total course cost,” you also need the recommended dose and intended treatment duration, not just the RMBW price.
If you meant “RMB” (China) pricing: what else should you check?
If you’re looking for the Chinese market price, also confirm:
- the specific brand/product line used for the RMBW entry,
- whether it’s the originator or an authorized local pack size,
- and whether the figure reflects any government-negotiated adjustments.
Quick clarification
What does “RMBW” mean for you (a specific dataset, regulatory document, or pricing platform), and what package size or strength are you referencing (e.g., per vial or per carton)? With that, I can help pin down the correct price context and avoid mixing list price with negotiated or imported pricing.
Sources:
[1] https://www.drugpatentwatch.com/